We are Theramex, a global speciality pharmaceutical company solely committed to supporting the health needs of women through every stage of life. We work on patient-focused, effective solutions that support women of all ages.
We work closely with our partners, healthcare professionals, and patients to provide women with the right solution, at the time they most need it.
Evorel product range
Evorel® 25, 50, 75, 100 estradiol patch (estradiol)
Indication: HRT for estrogen deficiency symptoms in peri- and post-menopausal women.1
Evorel® Sequi (estradiol and norethisterone acetate)
Evorel® Sequi is composed of Evorel® 50 and Evorel® Conti
Indication: HRT for estrogen deficiency symptoms in peri- and post-menopausal women.2
Evorel® Conti (estradiol and norethisterone acetate)
Indication: HRT for estrogen deficiency symptoms in post-menopausal women more than 6 months post-menopause (or 18 months since last period).3
References: 1. Evorel® Patch Summary of Product Characteristics. 2. Evorel® Sequi Summary of
Product Characteristics. 3. Evorel® Conti Summary of Product Characteristics.
HRT: hormone replacement therapy
AE reporting:
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to Theramex on medinfo.uk@theramex.com or Tel: 0333 0096795
Link:
Link to PI:
https://www.doctors.net.uk/_datastore/PI/2023/theramex/evorel-hrt-pi.pdf
Job code: Evor_GB_BANNERAD_009334
Date of preparation: March 2023
